Description
AbemaciclibisaCDK4andCDK6inhibitorfoundtoinhibitretinoblastomaphosphorylation,leADIngtoG1/SarrestinER+breastcancercellsandtopromotemetabolicalterationsinmetastaticHR+breastcancercells.
AbemaciclibisaCDK4andCDK6inhibitorfoundtoinhibitretinoblastomaphosphorylation,leADIngtoG1/SarrestinER+breastcancercellsandtopromotemetabolicalterationsinmetastaticHR+breastcancercells.
CasNo. | 1231930-82-7 |
---|---|
Purity | ≥98% |
Formula | C27H32F2N8•CH4O3S |
FormulaWt. | 602.71 |
ChemicalName | N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-aminemethanesulfonate |
Synonym | LY2835219methanesulfonate |
StoreTemp | -20°C |
---|---|
ShipTemp | BlueIce |
InfoSheet | A044178InfoSheetPDF |
---|
Torres-GuzmanR,CalsinaB,HermosoA,etal.Preclinicalcharacterizationofabemaciclibinhormonereceptorpositivebreastcancer.Oncotarget.2017May10.Epubaheadofprint.PMID:28537883
TateSC,BurkeTF,HartmanD,etal.OptimisingthecombinationdosingstrategyofabemaciclibandvemurafenibinBRAF-mutatedmelanomaxenografttumours.BrJCancer.2016Mar15;114(6):669-679.PMID:26978007
KnudsenES,HutchesonJ,VailP,etal.BIOLOGicalspecificityofCDK4/6inhibitors:doseresponserelationship,invivosignaling,andcompositeresponsesignature.Oncotarget.2017Jun10.Epubaheadofprint.PMID:28620137